Rescheduled CPhI South East Asia to now take place in November

Amsterdam, 4 May 2020: CPhI South East Asia – organised by Informa Markets –  has postponed its rescheduled event to November 4-6, 2020 to provide more time for positive business conditions to return and for global disruption to ease.

“Moving the event to November will further mitigate the impact of ongoing travel restrictions and provide more time for normality and confidence to return to the market. Our aim is to deliver a better overall platform for exhibitors and visitors to engage. It was a difficult decision, but a vital one, to ensure both the safety and integrity of the event,” commented Silvia Forroova, Brand Director at Informa Markets.

Informa Markets will continue to host the event at the Impact, Muang Thong, Thani and is reaching out to all participants with detailed information.

“It’s a dynamic situation globally, but we have tried to maintain as much communication with attendees as possible and we would like to thank those who participate and support CPhI South East Asia. We greatly appreciate your patience, understanding, and help in continuing to deliver the best possible outcome. With this in mind, and to help maintain business relationships in the meantime, we are looking at new ways to stay connected and bring greater value to the South East Asia pharma community.” added Forroova.

-ENDS-

Notes to editors

About CPhI

CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, Korea, China, India, Japan, South East Asia, North America, and the Middle East and Africa. Co-locating with ICSE for contract services; P-MEC for machinery, equipment & technology; InnoPack for pharmaceutical packaging; bioLIVE for biopharma; Finished Dosage Formulation for every aspect of the finished dosage supply chain; and NEX for natural extract products, applications and solutions.  CPhI provides an online buyer and supplier directory at CPhI-Online.com.

For more information visit https://www.cphi.com

About Informa Markets

Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organiser, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year.

For more information, please visit www.informamarkets.com.

The Informa Markets annual schedule of Pharmaceutical events include: CPhI Korea (26-28 August, 2020 at COEX – Seoul, Korea); CPhI North America (9 - 11 September, 2020 at Pennsylvania Convention Centre – Philadelphia, USA); CPhI Middle East & Africa (14-16 September, 2020 at the ADNEC – Abu Dhabi, United Arab Emirates); CPhI Japan (30 September – 2 October, 2020 at Intex Osaka Exhibition Center – Osaka, Japan); CPhI, ICSE, P-MEC, FDF, InnoPack Worldwide, BioProduction (13-15 October, 2020 at Fiera Milano, Milan); CPhI South East Asia (4-6 November, 2020 at IMPACT Center – Bangkok, Thailand); CPhI & P-MEC India (25–27 November 2020 at the India Expo Mart, Greater Noida, Delhi NCR – Delhi, India); CPhI and P-MEC China (16-18 December, 2020 at SNIEC – Shanghai, China); Pharmapack Europe (27-28 January 2021 at Paris Expo, Porte de Versailles – Paris, France).

For media enquiries, please contact:

Alex Heeley or Abdul Khalifeh

De Facto Communications

T: +44 (0) 203 735 8168

E: a.heeley@defacto.com / a.khalifeh@defacto.com